GLP-1s are doing something important: they're pushing prevention and long-term wellness into everyday conversations in a way few interventions have before
Upon activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), berberine enhances insulin sensitivity, reduces hepatic glucose output, and has been shown in animal models to increase GLP-1 secretion, although this mechanism has not yet been confirmed in large human trials
GLP-1s help to stimulate insulin release and reduce glucagon production
Tirzepatide, despite its strength, doesnt necessarily entail a higher risk of these rare, severe side effects
Less water means smaller injections and longer vial life, but higher risk of measurement errors
Clinical Oversight & Safety Clinical services provided through Beluga Health (led by Dr